Fernanda Daniela Dornelas Nunes

Dr. Fernanda Daniela Dornelas Nunes

Psychiatric Nursing, University of the State of Minas Gerais, Passos, Minas Gerais, Brazil
+1
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2016
Verified
Journal Article
Closed access
Fernanda Daniela Dornelas NunesFernanda Daniela Dornelas Nunes
Fernanda Daniela Dornelas Nunes
PFPedro Henrique Batista de Freitas
Pedro Henrique Batista de Freitas
JPJeizziani Aparecida Ferreira Pinto
Jeizziani Aparecida Ferreira Pinto
ASAndreia Roberta Silva e Souza
Andreia Roberta Silva e Souza
RMRichardson Miranda Machado
Richardson Miranda Machado

1 January 2017 in Epidemiologia e Serviços de Saúde
Verified
Journal Article
Open access
EGEliete Albano de Azevedo Guimarães
Eliete Albano de Azevedo Guimarães
CVCarolina Santiago Vieira
Carolina Santiago Vieira
Fernanda Daniela Dornelas NunesFernanda Daniela Dornelas Nunes
Fernanda Daniela Dornelas Nunes
GJGabriela da Cunha Januário
Gabriela da Cunha Januário
VOValéria Conceição de Oliveira
Valéria Conceição de Oliveira
JTJacqueline Domingues Tibúrcio
Jacqueline Domingues Tibúrcio
To estimate prematurity prevalence and associated factors in Divinópolis, Minas Gerais state, Brazil, 2008-2011. this is a cross-sectional study with data from 9,987 records held on the Information System on Live Births; a multiple logistic regression model was used. prevalence of preterm births was 8.0%; the higher likelihood of premature newborns were found to cesarean section (8.9%), mothers aged 15 or less (14.4%) and aged 35 or more (9.3%), mothers who went to 6 or fewer prenatal care visits (16.0%), and had had 4 or more live births (11.7%); after adjustment, the odds of preterm birth was higher among mothers aged under 15 years old (OR=1.22; 95%CI 1.01;1.49), mothers with 6 or fewer prenatal care visits (OR=3.76; 95%CI 3.24;4.38) and mothers undergoing cesarean section (OR=1.73; 95%CI 1.48;2.04). prematurity was associated with cesarean delivery, having fewer than 7 prenatal care visits and lower maternal age.

9 December 2022 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Fernanda Daniela Dornelas NunesFernanda Daniela Dornelas Nunes
Fernanda Daniela Dornelas Nunes
LFLetícia Perticarrara Ferezin
Letícia Perticarrara Ferezin
SPSherliane Carla Pereira
Sherliane Carla Pereira
FFFernanda Viana Figaro-Drumond
Fernanda Viana Figaro-Drumond
LPLucas Cézar Pinheiro
Lucas Cézar Pinheiro
Riccardo LacchiniRiccardo Lacchini
Riccardo Lacchini
VEGF is an important neurotrophic and vascular factor involved in mental disorders. The objective of this study was to verify the effect of genetic polymorphisms in the VEGF pathway on the risk for depression, symptom intensity, and suicide attempts. To examine the association between the VEGF pathway and depression, we genotyped polymorphisms and measured the plasma concentrations of VEGF, KDR, and FLT1 proteins. The participants were 160 patients with depression and 114 healthy controls. The questionnaires that assessed the clinical profile of the patients were the MINI-International Neuropsychiatric Interview, GRID-HAMD21, CTQ, BSI, and the number of suicide attempts. Genotyping of participants was performed using the real-time PCR and protein measurements were performed using the enzyme-linked immunosorbent assay (ELISA). VEGF and its inhibitors were reduced in depression. Individuals with depression and displaying the homozygous AA of the rs699947 polymorphism had higher plasma concentrations of VEGF (p-value = 0.006) and were associated with a greater number of suicide attempts (p-value = 0.041). Individuals with depression that were homozygous for the G allele of the FLT1 polymorphism rs7993418 were associated with lower symptom severity (p-value = 0.040). Our results suggest that VEGF pathway polymorphisms are associated with the number of suicide attempts and the severity of depressive symptoms.

1 January 2020 in Revista Latino-Americana de Enfermagem
Verified
Journal Article
Open access
PDF file
JMJordana Carvalhaes de Moraes
Jordana Carvalhaes de Moraes
Fernanda Daniela Dornelas NunesFernanda Daniela Dornelas Nunes
Fernanda Daniela Dornelas Nunes
FCFernanda Borchers Coeli-Lacchini
Fernanda Borchers Coeli-Lacchini
AMAnderson Heiji Lima Miyazaki
Anderson Heiji Lima Miyazaki
MFMilena Flória-Santos
Milena Flória-Santos
Riccardo LacchiniRiccardo Lacchini
Riccardo Lacchini
Objective: to verify the existence of elements that justify the use of pharmacogenetics by the Brazilian nurse. Method: this is a quantitative, cross-sectional, observational, descriptive study, whose final sample was 67 individuals. The participants were healthy at the time of the study and reported a history of previous use and the occurrence of adverse effects by drugs commonly used and metabolized by CYP2C9. We collected 4 mL of venous blood for subsequent DNA extraction by salting out method and genotyping of the CYP2C9*2 and CYP2C9*3 polymorphisms, using Polymerase Chain Reaction in real time using Taqman assays. Results: the use of drugs metabolized by CYP2C9 was frequent (more than 75% of the individuals have already used between 2 or 4 of these drugs). Regarding adverse events, there were 19 perceived symptomatic occurrences associated with drugs metabolized by CYP2C9. The allele frequency of the polymorphism * 2 and * 3 in the population studied was 11.1% and 7.5%, respectively, and there was a coincidence between the presence of alleles of low enzyme activity and the occurrence of adverse effects. Conclusion: there are elements that justify the adoption of pharmacogenetics in the nursing care to reduce the occurrence of adverse reactions to drugs metabolized by CYP2C9.

28 April 2016 in Revista de Enfermagem do Centro Oeste Mineiro
Verified
Journal Article
Open access
PDF file
Fernanda Daniela Dornelas NunesFernanda Daniela Dornelas Nunes
Fernanda Daniela Dornelas Nunes
PFPedro Henrique Batista De Freitas
Pedro Henrique Batista De Freitas
JPJeizziani Aparecida Ferreira Pinto
Jeizziani Aparecida Ferreira Pinto
PSPaulo Henrique Alves De Sousa
Paulo Henrique Alves De Sousa
CEClarice De Lourdes Enes
Clarice De Lourdes Enes
RMRichardson Miranda Machado
Richardson Miranda Machado
A esquizofrenia é denominada refratária quando os pacientes não apresentam melhora dos principais sintomas mesmo após o tratamento com dois antipsicóticos de classes diferentes, em doses adequadas e regulares. Em comparação com a população geral pessoas com esquizofrenia apresentam um risco aumentado para alterações metabólicas. O presente artigo foi elaborado com o objetivo de caracterizar os pacientes que possuem diagnóstico de esquizofrenia refratária que fazem uso do antipsicótico atípico clozapina e que apresentam ou não a síndrome metabólica residentes na Região Ampliada Oeste de Minas Gerais. Trata-se de um estudo epidemiológico e transversal. A amostra foi composta por 72 pacientes pertencentes à região Ampliada Oeste de Minas Gerais. Foram coletados dados sociodemográficos, clínicos, antropométricos e bioquímicos. Realizou-se análise descritiva dos dados. Observou-se que a presença de síndrome metabólica em mulheres (58,8%) foi superior aos homens (41,2%). Os pacientes apresentaram percentuais mais elevados de alterações nos componentes da síndrome, principalmente glicemia e triglicérides. 65% dos pacientes fazem uso de quatro ou mais medicamentos e 47,1% dos indivíduos apresentaram sobrepeso e 38,2% obesidade. Sugere-se a construção de estratégias de prevenção primária das alterações metabólicas, bem como a monitoração continuada de suas questões clínicas, principalmente em relação aos componentes da síndrome.

1 January 2019 in Genetics and Molecular Research
Verified
Journal Article
Closed access
Fernanda Daniela Dornelas NunesFernanda Daniela Dornelas Nunes
Fernanda Daniela Dornelas Nunes
JPJ.A.F. Pinto
J.A.F. Pinto
PFP.H.B. Freitas
P.H.B. Freitas
LSL.L. Santos
L.L. Santos
RMR.M. Machado
R.M. Machado